ABL Bio Inc (298380.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea · ISIN KR7298380007
ABL Bio Inc financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 33.40 bn KRW | 79.35 bn KRW |
| Gross profit | 33.40 bn KRW | 79.35 bn KRW |
| Operating income | -59.38 bn KRW | -40.28 bn KRW |
| EBIT | -55.49 bn KRW | -36.88 bn KRW |
| Net income | -55.53 bn KRW | -37.81 bn KRW |
| Diluted EPS – continuing operations | -1,150.11 KRW | -685.83 KRW |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ABL Bio Inc
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. The company offers ABL301, which is in the phase 1 clinical stage for the treatment of parkinson's disease; ABL503 and ABL111 that is in phase 1 clinical stage for the treatment of solid tumor; and ABL102 for the treatment of solid and blood tumor. It also provides ABL103 for the treatment solid cancers; ABL104 for the treatment of solid tumor; and ABL105, which is in phase 1 clinical stage for the treatment of solid tumor. ABL Bio Inc. was incorporated in 2016 and is based in Seoul, South Korea.
More stocks
- Hsino Tower Group Co., Ltd. (601096.SS)
- CAPITAL SOUTHWEST CORP (CSWC)
- CRACKER BARREL OLD COUNTRY STORE, INC (CBRL)
- SRG Global Ltd (SRG.AX)
- Thinkon Semiconductor Jinzhou Corp (688233.SS)
- A.F.P. Provida (PROVIDA.SN)
- Grupo Mateus S.A (GMAT3.SA)
- Toyou Feiji Electronics Co Ltd (300302.SZ)
- UMS Integration Limited (5340.KL)
- Proto Labs Inc (PRLB)
- PHOTRONICS INC (PLAB)
- Nationwide Building Society (NBS.L)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.